Top Page
Centrica
(LSE:CNA)
Centrica (CNA) vs. iShares MSCI United Kingdom ETF (EWC)
Centrica Business Overview & Revenue Model
Centrica Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.43B | 19.91B | 26.46B | 23.74B | 14.74B | 12.25B |
| Gross Profit | 5.52B | 4.09B | -1.70B | 9.75B | 1.41B | 3.52B |
| EBITDA | 2.01B | 2.42B | 7.30B | 410.00M | 721.00M | 488.00M |
| Net Income | -118.50M | 1.33B | 3.93B | -782.00M | 586.00M | 41.00M |
Balance Sheet | ||||||
| Total Assets | 16.21B | 18.73B | 21.37B | 29.04B | 27.09B | 17.12B |
| Cash, Cash Equivalents and Short-Term Investments | 5.38B | 6.22B | 6.85B | 4.84B | 5.06B | 1.82B |
| Total Debt | 2.93B | 3.51B | 4.10B | 3.96B | 4.58B | 5.29B |
| Total Liabilities | 12.52B | 13.92B | 17.13B | 27.76B | 24.34B | 15.74B |
| Stockholders Equity | 3.30B | 4.42B | 3.88B | 1.02B | 2.37B | 957.00M |
Cash Flow | ||||||
| Free Cash Flow | 276.00M | 733.00M | 2.42B | 943.00M | 1.19B | 778.00M |
| Operating Cash Flow | 633.00M | 1.15B | 2.75B | 1.31B | 1.61B | 1.27B |
| Investing Cash Flow | -166.00M | 493.00M | 115.00M | -566.00M | 2.26B | -354.00M |
| Financing Cash Flow | -989.00M | -1.55B | -1.41B | -917.00M | -938.00M | -280.00M |
Centrica Technical Analysis
Centrica Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £3.10B | 8.25 | 19.64% | 2.78% | -19.04% | -34.52% | |
76 Outperform | £61.67B | 21.18 | 7.87% | 4.15% | -9.52% | 35.74% | |
74 Outperform | £29.06B | 27.69 | 9.92% | 2.98% | 1.78% | -50.72% | |
66 Neutral | £8.67B | -38.77 | -5.95% | 2.86% | -4.82% | -123.58% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
63 Neutral | £1.06B | 15.88 | 28.80% | 7.01% | 1.71% | -12.49% | |
58 Neutral | £22.05M | -1.13 | -68.06% | ― | -60.76% | -230.39% |
Centrica Corporate Events
Centrica plc has confirmed that as of 31 January 2026 its issued share capital totals 5,064,902,964 ordinary shares, of which 460,040,495 are held in treasury. This leaves 4,604,862,469 shares in circulation carrying one vote per share, a figure the company highlights as the key denominator for shareholders and other obligated parties when calculating whether they must disclose holdings or changes in their interests under UK transparency rules.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £206.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has disclosed that non-executive directors Philippe Boisseau and Sue Whalley have acquired ordinary shares in the company through pre-agreed Share Purchase Agreements executed via Equiniti Financial Services. On 26 January 2026, Boisseau bought 1,021 shares and Whalley purchased 530 shares at a price of £1.841730 per share on the London Stock Exchange, signalling incremental director alignment with shareholder interests under the company’s standard governance and remuneration arrangements.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £2.18 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has disclosed that executive directors Christopher O’Shea and Russell O’Brien have each acquired ordinary shares under the company’s Share Incentive Plan, in line with regulatory requirements for reporting transactions by persons discharging managerial responsibilities. The acquisitions, comprising both partnership and matching shares administered by Equiniti Share Plan Trustees, are relatively small in value but underscore ongoing alignment between senior management and shareholders, and reflect the routine operation of Centrica’s employee share ownership arrangements.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £2.18 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has completed the £500 million extension of its share buyback programme, part of a wider capital return initiative launched in November 2022 that has seen the company repurchase about £2.0 billion of its ordinary shares, equivalent to roughly 25% of its then-issued share capital. The company disclosed that on 12 January 2026 it bought 84,365 shares at an average price of 180.8081 pence through J.P. Morgan Securities, taking total purchases since September 2025 to 147,027,443 shares and leaving 460,124,571 shares held in treasury out of 4,604,778,393 shares in issue (excluding treasury), underscoring an ongoing focus on capital allocation and shareholder returns.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £2.18 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has continued executing the second tranche of its share buyback programme, repurchasing 201,235 ordinary shares on 9 January 2026 at a volume-weighted average price of 178.9655 pence per share via J.P. Morgan Securities. Since the start of this tranche in September 2025, the company has bought back 146.9 million shares for approximately £249.8 million (excluding costs), and now holds 460 million shares in treasury, leaving about 4.6 billion shares in issue, a move that effectively reduces the free float and can enhance earnings per share and capital returns for remaining shareholders.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £2.18 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has continued executing the second tranche of its share buyback programme, repurchasing 1,058,825 ordinary shares on 9 January 2026 at a volume-weighted average price of 180.4105 pence per share via J.P. Morgan Securities, with the shares to be held in treasury. Since the buyback was launched in September 2025, the group has acquired 147.8 million shares for just over £251 million, leaving 460.9 million shares in treasury and 4.60 billion shares in issue, underlining an ongoing capital return to investors and a tighter free float that may support earnings per share over time.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £2.18 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has continued executing the second tranche of its share buyback programme, repurchasing 1,098,671 ordinary shares on 8 January 2026 at a volume-weighted average price of 176.5799 pence per share via J.P. Morgan Securities, with the shares to be held in treasury. Since the programme’s launch on 22 September 2025, the company has acquired a total of 146,741,843 shares for approximately £249.5 million, lifting its treasury holdings to 459,841,213 shares and leaving 4,605,061,751 shares in issue, a move that tightens the free float and underscores Centrica’s ongoing capital return strategy for shareholders.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has continued the second tranche of its share buyback programme by repurchasing 1,088,950 ordinary shares on 7 January 2026 at a volume-weighted average price of 176.5194 pence per share, with the shares to be held in treasury. Since launching this phase of the programme in September 2025, the company has bought back 145.6 million shares for approximately £247.5 million, bringing its total treasury holding to about 458.7 million shares and leaving 4.61 billion shares in issue, a capital structure move that can support earnings per share and signal management’s confidence to investors.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has continued the second tranche of its share buyback programme, repurchasing 1,097,563 ordinary shares on 6 January 2026 at a volume-weighted average price of 175.4889 pence per share through J.P. Morgan Securities, with the shares to be held in treasury. Since the start of this tranche on 22 September 2025, the company has bought back 144,554,222 shares at a cost of about £245.6m, leaving it with 457,653,592 shares held in treasury and 4,607,249,372 shares in issue, underlining an ongoing capital return to shareholders and tighter management of its equity base.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has continued execution of its share buyback programme, repurchasing 1,121,853 ordinary shares on 5 January 2026 at a volume-weighted average price of 172.9334 pence per share through J.P. Morgan Securities, with the shares to be held in treasury. Since the launch of this second tranche of the buyback in September 2025, the company has acquired 143,456,659 shares for approximately £243.7 million, bringing its treasury holdings to 456,556,029 shares and reducing the free float to 4,608,346,935 shares in issue, a move that signals continued capital returns to shareholders and may support earnings per share by shrinking the equity base.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has continued execution of the second tranche of its share buyback programme, repurchasing 1,120,369 ordinary shares on 2 January 2026 at a volume-weighted average price of 173.33 pence per share via J.P. Morgan Securities, with the shares to be held in treasury. Since the programme began in September 2025, the group has bought back more than 142 million shares for around £241.8 million, lifting treasury holdings to roughly 455 million shares and reducing the free float to about 4.61 billion shares, a move that tightens the share count and may enhance earnings per share and capital returns for remaining investors.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has reported that, as of 31 December 2025, its issued share capital totalled 5,064,902,964 ordinary shares, of which 454,315,003 are held in treasury, leaving 4,610,587,961 shares in circulation with full voting rights. The company confirmed that this voting share figure should be used by investors and other obligated parties as the denominator when calculating whether they need to disclose holdings or changes in their interests under UK transparency regulations, ensuring clarity on ownership thresholds and regulatory compliance for shareholders.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has continued executing the second tranche of its share buyback programme, repurchasing 1,140,716 ordinary shares on 31 December 2025 at an average price of 170.2163 pence per share via J.P. Morgan Securities, with the shares to be held in treasury. Since the buyback’s launch in September 2025, the company has acquired 141,214,437 shares for approximately £239.8 million, taking its treasury holding to 454.3 million shares and leaving 4.61 billion shares in issue, underscoring an ongoing capital return strategy that reduces the free float and can enhance earnings per share for remaining shareholders.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has continued its ongoing share buyback programme, purchasing 1,136,420 ordinary shares on 30 December 2025 at a volume-weighted average price of 169.8045 pence per share through J.P. Morgan Securities, with the shares to be held in treasury. Since the launch of the second tranche of the buyback in late September, the company has repurchased over 140 million shares at a cost of approximately £238 million, bringing its treasury holding to 453.2 million shares and leaving 4.61 billion shares in issue, signalling sustained capital returns to shareholders and active management of its equity base.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has continued executing the second tranche of its share buyback programme, repurchasing 1,154,459 ordinary shares on 29 December 2025 at an average price of 168.7104 pence per share through J.P. Morgan Securities, with the shares to be held in treasury. Since the buyback’s launch on 22 September 2025, the company has acquired 138,937,301 shares for approximately £235.9 million, leaving 4,612,865,097 shares in issue excluding 452,037,867 shares now held in treasury, underscoring management’s ongoing capital return to shareholders and its active management of the company’s equity base.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has cancelled 35,704,250 ordinary shares previously held in treasury, in line with its policy to keep treasury shares below 10% of total issued share capital. Following the cancellation, the company now holds 450,883,408 ordinary shares in treasury, representing 8.90% of its total issued share capital, with 4,614,019,556 voting rights remaining in issue, a move that modestly adjusts its capital structure and share base for investors.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has disclosed that non-executive directors Philippe Boisseau and Sue Whalley have acquired additional ordinary shares in the company under previously agreed Share Purchase Agreements. The purchases, executed on 29 December 2025 on the London Stock Exchange at £1.6835 per share, involved 1,116 shares for Boisseau and 579 shares for Whalley, signalling continued board-level alignment with shareholder interests through increased personal equity stakes.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has continued executing the second tranche of its share buyback programme, repurchasing 1,156,316 ordinary shares on 24 December 2025 at an average price of 168.8752 pence per share via J.P. Morgan Securities, with the shares to be held in treasury. Since the start of this tranche in September, the company has bought back 137.8 million shares for nearly £234 million, bringing its treasury holding to about 486.6 million shares and reducing the free float to 4.61 billion shares, underscoring an ongoing capital return strategy that may enhance earnings per share and support shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has continued the second tranche of its share buyback programme with the repurchase of 1,150,322 ordinary shares on 23 December 2025 at an average price of 168.8074 pence per share, with the stock to be held in treasury. Since the programme began on 22 September 2025, the company has bought back a total of 136,626,526 shares for approximately £232 million, leaving 4,615,175,872 shares in issue excluding 485,431,342 shares now held in treasury, underscoring management’s ongoing focus on returning capital to shareholders and actively managing the company’s capital structure.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has continued to execute the second tranche of its share buyback programme, repurchasing 1,150,354 ordinary shares on 22 December 2025 at an average price of 167.8956 pence per share through J.P. Morgan Securities, with the shares to be held in treasury. Since the launch of this phase of the programme on 22 September 2025, the group has bought back more than 135 million shares for about £230.1 million, leaving 4.62 billion shares in issue (excluding 484.3 million held in treasury), a move that effectively concentrates earnings per share and signals ongoing balance sheet strength and commitment to shareholder returns.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has continued executing the second tranche of its share buyback programme, repurchasing 1,127,771 ordinary shares on 19 December 2025 at a volume-weighted average price of 168.8858 pence per share through J.P. Morgan Securities, with the stock to be held in treasury. Since the programme’s launch on 22 September 2025, the company has bought back 134,325,850 shares for approximately £228.2 million, bringing its treasury holding to 483,138,586 shares and reducing the free float to 4,617,468,628 shares, a capital management move that can enhance earnings per share and signals continued confidence in its balance sheet to investors.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced a board-level change, with Non‑Executive Director Heidi Mottram stepping down from the Board on 31 December 2025 after serving since January 2020 and playing a key role on the Nominations and Remuneration Committees, as well as chairing the Safety, Environment and Sustainability Committee. Former UK minister Amber Rudd will assume the role of Chair of the Safety, Environment and Sustainability Committee and will join the Nominations Committee from 1 January 2026, a move that underscores Centrica’s continued focus on governance, sustainability oversight and strategic board refreshment as it navigates the evolving energy and regulatory landscape.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has continued the second tranche of its share buyback programme, repurchasing 1,150,079 ordinary shares on 18 December 2025 at a volume-weighted average price of 167.0738 pence per share through J.P. Morgan Securities, with the shares to be held in treasury. Since the current programme began in September, the company has bought back 133,198,079 shares at a cost of about £226.3 million, bringing its treasury holding to 482,010,815 shares and leaving 4,618,596,399 shares in issue, signalling ongoing efforts to return capital to shareholders and manage its capital structure by reducing free-float equity.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has executed a share buyback transaction, repurchasing over 1.16 million shares at an average price of 166.7032 pence as part of its ongoing buyback program initiated in September 2025. This initiative, which has so far involved the repurchase of 132 million shares totaling over £224 million, reflects the company’s commitment to optimizing shareholder value and actively managing its capital allocation strategy.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,136,530 of its own ordinary shares at an average price of 167.5108 pence per share, as part of its ongoing share buyback program. This transaction is part of the second tranche of the buyback initiative, which began on September 22, 2025, and reflects Centrica’s strategy to manage its capital structure effectively. The company now holds 477,074,737 shares in treasury, indicating a significant effort to return value to shareholders and potentially enhance earnings per share.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has announced the sale of Spirit Energy’s remaining 15% interest in the Cygnus gas field and other assets in the Greater Markham Area and Southern North Sea to Serica Energy for approximately £98 million. This transaction aligns with Centrica’s strategy to streamline its portfolio, focus on new investment opportunities, and support the energy transition by investing in projects like the Morecambe Net Zero carbon storage initiative. The sale is expected to complete in the second half of 2026, subject to regulatory approvals.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 6,427,619 of its own ordinary shares at an average price of 165.4532 pence per share, as part of its ongoing share buyback program initiated on 22 September 2025. This move is part of a broader strategy to manage its capital structure and return value to shareholders, with the company having acquired a total of 127,125,471 shares since the program’s inception, costing over £216 million. The shares will be held in treasury, impacting the total number of shares in circulation and potentially influencing the company’s stock price and shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 4,238,678 ordinary shares at a price of 166.2484 pence per share, as part of its ongoing share buyback program. This transaction, executed through J.P. Morgan Securities plc, is part of the second tranche of the buyback initiative, which began on 22 September 2025. The company has acquired a total of 120,697,852 shares since the program’s inception, costing approximately £205.5 million. The repurchased shares will be held in treasury, increasing Centrica’s treasury holdings to 469,510,924 shares, while the total number of shares in issue remains at 4,631,096,290. This strategic move is likely to enhance shareholder value by reducing the number of shares in circulation, potentially increasing earnings per share and providing a return of capital to shareholders.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the acquisition of ordinary shares under its Share Incentive Plan by its Executive Directors, Christopher O’Shea and Russell O’Brien. The transactions involved acquiring Partnership and Matching Shares, with a total of 111 and 112 shares acquired by O’Shea and O’Brien, respectively. This move reflects the company’s ongoing commitment to aligning its executives’ interests with shareholder value, potentially impacting its market perception and stakeholder confidence.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £205.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,271,048 of its own ordinary shares at an average price of 167.3014 pence per share, as part of its ongoing share buyback program initiated in September 2025. This move is part of a broader strategy to optimize capital structure and return value to shareholders, with significant implications for the company’s market positioning and shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £182.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 3,007,770 of its own ordinary shares at a price of 167.9331 pence per share as part of its ongoing buyback program. This move, executed through J.P. Morgan Securities, is part of the second tranche of the buyback initiative announced in September 2025, reflecting Centrica’s strategy to manage its capital structure and enhance shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £182.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 2,230,475 of its own ordinary shares at an average price of 168.6131 pence per share as part of its ongoing buyback program. This transaction, executed through J.P. Morgan Securities, is part of a larger effort that has seen the company repurchase over 111 million shares since September, reflecting a strategic move to consolidate its share capital and potentially enhance shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £182.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has executed a significant share buyback, purchasing 1,179,342 of its ordinary shares at an average price of 169.3347 pence per share, as part of its ongoing buyback program initiated in September 2025. This move is part of Centrica’s strategy to manage its capital structure and return value to shareholders, potentially enhancing its market position and signaling confidence in its financial health.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £182.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,145,067 of its own ordinary shares at a price of 170.5181 pence per share, as part of its ongoing share buyback program. This move is part of the second tranche of the buyback initiative, which began on September 22, 2025, and aims to enhance shareholder value by reducing the number of shares in circulation. The company now holds 456,672,936 shares in treasury, impacting its share capital structure and potentially influencing market perceptions and shareholder returns.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £198.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,155,019 of its own ordinary shares at a price of 168.8213 pence per share, as part of its ongoing share buyback program. This acquisition is part of the second tranche of the buyback initiative, which began on 22 September 2025, and is aimed at optimizing the company’s capital structure. As a result of this transaction, Centrica now holds 455,527,869 shares in treasury, with 4,645,079,345 shares remaining in circulation. This move is expected to enhance shareholder value and reflects Centrica’s strategic focus on returning capital to shareholders.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £198.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,151,419 of its own ordinary shares at an average price of 169.2431 pence per share, as part of its ongoing share buyback program. This transaction is part of a larger initiative that began in September 2025, aimed at consolidating the company’s share capital and potentially enhancing shareholder value. As a result, Centrica now holds 454,372,850 shares in treasury, with 4,646,234,364 shares remaining in circulation. This move is expected to impact the company’s financial structure and market perception positively.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £198.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,137,036 of its own ordinary shares at a price of 170.5484 pence per share, as part of its ongoing share buyback program. This move is part of the second tranche of the buyback initiative, which began on 22 September 2025, and reflects the company’s strategy to enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £198.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced its total voting rights as of November 30, 2025, with an issued capital comprising over 5.1 billion ordinary shares. Out of these, approximately 4.65 billion shares have voting rights, which stakeholders can use to determine their notification obligations under the Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £198.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,136,288 of its own ordinary shares at a price of 170.8506 pence each, which will be held as treasury shares. This transaction is part of the second tranche of the company’s buyback program, which has seen a total purchase of 103,181,998 shares since September 2025, costing £176,086,712.21. The buyback program is likely to impact Centrica’s financial structure by potentially increasing shareholder value and optimizing capital allocation.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £198.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has completed the acquisition of the Grain LNG terminal in partnership with Energy Capital Partners for £1.5 billion. This strategic investment is part of Centrica’s effort to enhance the UK’s energy security and pivot towards stable infrastructure earnings. The acquisition aligns with Centrica’s broader investment strategy, which includes significant commitments to projects like Sizewell C and the redevelopment of the Rough gas storage facility, contingent on supportive regulatory frameworks.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £198.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has executed a share buyback transaction, purchasing over 1.1 million of its ordinary shares at an average price of 169.6789 pence per share. This purchase is part of the company’s ongoing buyback program, which has seen over 102 million shares bought back since September 2025, reflecting Centrica’s strategy to return value to shareholders and optimize its capital structure.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £165.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,189,730 of its own ordinary shares at a price of 163.8691 pence per share, as part of its ongoing share buyback program. This strategic move is part of a larger initiative that began on 22 September 2025, where the company has already acquired over 100 million shares, reflecting a significant investment in its own equity. The repurchased shares will be held as treasury shares, which could potentially enhance shareholder value by reducing the number of shares in circulation and improving earnings per share.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £165.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,198,016 of its own ordinary shares at an average price of 163.6947 pence per share, as part of its ongoing buyback programme. This move, part of a larger initiative that began in September 2025, reflects Centrica’s strategy to manage its capital structure effectively and potentially enhance shareholder value. The company now holds a significant number of shares in treasury, indicating a strong commitment to its buyback strategy, which may impact its market positioning and shareholder relations.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £165.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced that its directors, Philippe Boisseau and Sue Whalley, have acquired ordinary shares in the company as part of their Share Purchase Agreements. These transactions, conducted on the London Stock Exchange, reflect ongoing commitments by the company’s leadership to align their interests with those of shareholders, potentially impacting investor confidence positively.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,240,457 of its own ordinary shares at an average price of 161.7394 pence per share, as part of its ongoing share buyback program. This move, executed through J.P. Morgan Securities, is part of a larger strategy to manage share capital and enhance shareholder value, with significant implications for the company’s financial structure and market perception.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 2,687,766 of its own ordinary shares at an average price of 163.1256 pence per share, as part of its ongoing share buyback program. This move, executed through J.P. Morgan Securities, reflects Centrica’s strategy to manage its capital structure and return value to shareholders, potentially enhancing its market position and investor confidence.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 3,681,142 of its own ordinary shares at an average price of 165.0322 pence per share, as part of its ongoing share buyback program. This move, executed through J.P. Morgan Securities plc, is part of the second tranche of the buyback initiative, aimed at optimizing the company’s capital structure and enhancing shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,715,368 of its own ordinary shares at an average price of 166.3897 pence per share, as part of its ongoing share buyback program. This transaction, executed through J.P. Morgan Securities, is part of a larger initiative that has seen the company repurchase over 88 million shares since September, reflecting a strategic move to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has announced that Nathan Bostock, currently a Non-Executive Director and Chair of the Audit and Risk Committee, will join Jupiter Fund Management plc as a non-executive director and Chair designate, effective March 2026. Bostock will continue his role at Centrica until July 2026, ensuring a smooth transition while maintaining his current responsibilities. This move highlights Centrica’s ongoing commitment to strong governance and leadership continuity.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has executed a significant share buyback, acquiring over 3 million ordinary shares at an average price of 166.5444 pence per share. This transaction is part of the second tranche of its buyback program, which has seen the company repurchase over 86 million shares since September 2025, reflecting a strategic move to consolidate its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,295,791 of its own ordinary shares at a price of 167.8239 pence per share, as part of its ongoing share buyback program. This transaction, executed through J.P. Morgan Securities plc, is part of the second tranche of the buyback initiative that began on 22 September 2025. Since the start of this program, Centrica has acquired over 83 million shares, reflecting a significant investment in its own equity. The move is likely to impact the company’s share value and demonstrates a commitment to returning value to shareholders.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 6,513,863 of its own ordinary shares at an average price of 168.1454 pence per share, as part of the second tranche of its buyback program. This move, executed through J.P. Morgan Securities, is part of a broader strategy to manage its capital structure and potentially enhance shareholder value. Since the start of the buyback program in September, Centrica has repurchased a total of 81,760,085 shares, reflecting a significant investment in its own equity, which could influence market perceptions and investor confidence.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the cancellation of 78,500,000 ordinary shares previously held in treasury, aligning with its policy to keep treasury shares below 10% of the total issued share capital. This move reduces the number of treasury shares to 8.32% of the total issued share capital, potentially impacting the company’s market positioning and shareholder value by optimizing its capital structure.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 3,398,444 of its own ordinary shares at a price of 171.6120 pence per share, as part of its ongoing share buyback program. This purchase is part of the second tranche of the program, which began on 22 September 2025, and aims to enhance shareholder value by reducing the number of shares in circulation. The company has acquired a total of 75,246,222 shares since the program’s inception, reflecting a strategic move to manage its capital structure and potentially increase earnings per share.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc, a leading energy company, has executed a significant share buyback, purchasing 1,881,103 of its own ordinary shares at an average price of 171.9881 pence per share. This transaction is part of the second tranche of its buyback program, which began on September 22, 2025. Since the start of the program, Centrica has acquired a total of 71,847,778 shares, reflecting a strategic move to enhance shareholder value and optimize capital structure.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 3,545,015 of its own ordinary shares at an average price of 173.0609 pence per share, as part of its ongoing share buyback program. This transaction, executed through J.P. Morgan Securities, is part of a broader strategy to enhance shareholder value and optimize the company’s capital structure, reflecting Centrica’s confidence in its financial stability and future prospects.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the acquisition of ordinary shares under its Share Incentive Plan by two of its executive directors, Christopher O’Shea and Russell O’Brien. This transaction, conducted on 11 November 2025, involved the purchase of Partnership Shares and Matching Shares, reflecting the company’s ongoing commitment to align management interests with shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of over 2 million of its own shares as part of its ongoing buyback program, which began in September 2025. This move, executed through J.P. Morgan Securities, reflects Centrica’s strategy to manage its capital structure and enhance shareholder value, holding a significant number of shares in treasury while maintaining a large number of shares in circulation.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,960,227 of its own ordinary shares at a price of 174.6643 pence per share, which will be held as treasury shares. This transaction is part of the second tranche of the company’s buyback program, initiated on 22 September 2025, and highlights Centrica’s ongoing strategy to manage its capital structure effectively. Since the start of the buyback program, Centrica has acquired a total of 64,314,289 shares, costing over £110 million. This move is expected to strengthen the company’s financial position and potentially enhance shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,256,086 of its own ordinary shares at an average price of 175.9679 pence per share, as part of the second tranche of its buyback program. This move, executed through J.P. Morgan Securities, is part of a larger strategy to repurchase shares, with the company having acquired over 61 million shares since September 2025. This buyback initiative is aimed at consolidating the company’s capital structure and potentially enhancing shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,346,087 of its own ordinary shares at a price of 176.6001 pence per share, as part of its ongoing share buyback program. This move, part of a larger buyback initiative announced in September 2025, indicates Centrica’s strategic effort to manage its capital structure and return value to shareholders, potentially impacting the company’s stock market performance and investor relations.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 1,701,068 of its own ordinary shares at a price of 178.4640 pence per share, which will be held as treasury shares. This purchase is part of the company’s ongoing buyback program, which has seen the acquisition of 56,751,889 shares since September 2025, costing approximately £97.5 million. This strategic move is likely to impact the company’s financial structure and shareholder value by reducing the number of shares in circulation, potentially increasing earnings per share and enhancing shareholder returns.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has completed its acquisition of a 15% equity stake in the Sizewell C nuclear power project, marking a significant investment in the UK’s energy future. This investment, totaling £376 million initially and expected to reach £500-600 million by 2028, underscores Centrica’s commitment to delivering zero-carbon power and supporting economic growth and energy security in Britain.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,767,828 of its own ordinary shares at an average price of 179.7894 pence per share, as part of its ongoing share buyback program. This move, executed through J.P. Morgan Securities, is part of a larger strategy to enhance shareholder value and optimize the company’s capital structure, with a total of 55,050,821 shares bought back since September 2025.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced its total voting rights as of October 31, 2025, with a total of 4,697,959,585 shares having voting rights. This figure is essential for shareholders and others with notification obligations to determine their interest in the company under the Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 1,630,477 of its own ordinary shares at an average price of 179.2801 pence per share, as part of its ongoing share buyback program. This transaction is part of the second tranche of the buyback initiative, which aims to enhance shareholder value and optimize the company’s capital structure, reflecting Centrica’s strategic focus on financial stability and shareholder returns.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.